BACKGROUND: Embryonal central nervous system (CNS) tumors are currently classified into three types: medulloblastoma, atypical rhabdoid/teratoid tumors, and primitive neuroectodermal tumor (PNET). A distinctive subtype of PNET called "embryonal tumor with abundant neuropil and true rosettes" (ETANTR) was reported in 2000. DISCUSSION: ETANTR is a recently described variety of PNET that combines microscopic features of neuroblastoma and ependymoblastoma, demonstrating areas of fine fibrillary neuropil intermingled with cellular zones and ependymoblastic rosettes. It has been suggested that this neoplasm should be considered as a separate entity. ETANTR is an eminently pediatric tumor that has been reported exclusively in children younger than 4 years. ILLUSTRATIVE CASES: A 9-month-old girl underwent subtotal resection of a brainstem neoplasm. A 23-month-old girl was submitted to surgery for a frontoparietal tumor. In both instances, the histopathological diagnosis confirmed ETANTR. Both children were treated with chemotherapy and one with radiotherapy. Death in both patients occurred after a mean period of 10 months. CONCLUSIONS: By reporting these two new instances of ETANTR, we want to contribute to the knowledge of this highly malignant CNS embryonal neoplasm that occurs only in young children, given its present lethal prognosis, the scarcity of reported cases, and the lack of treatment guidelines.
BACKGROUND:Embryonal central nervous system (CNS) tumors are currently classified into three types: medulloblastoma, atypical rhabdoid/teratoid tumors, and primitive neuroectodermal tumor (PNET). A distinctive subtype of PNET called "embryonal tumor with abundant neuropil and true rosettes" (ETANTR) was reported in 2000. DISCUSSION: ETANTR is a recently described variety of PNET that combines microscopic features of neuroblastoma and ependymoblastoma, demonstrating areas of fine fibrillary neuropil intermingled with cellular zones and ependymoblastic rosettes. It has been suggested that this neoplasm should be considered as a separate entity. ETANTR is an eminently pediatric tumor that has been reported exclusively in children younger than 4 years. ILLUSTRATIVE CASES: A 9-month-old girl underwent subtotal resection of a brainstem neoplasm. A 23-month-old girl was submitted to surgery for a frontoparietal tumor. In both instances, the histopathological diagnosis confirmed ETANTR. Both children were treated with chemotherapy and one with radiotherapy. Death in both patients occurred after a mean period of 10 months. CONCLUSIONS: By reporting these two new instances of ETANTR, we want to contribute to the knowledge of this highly malignant CNS embryonal neoplasm that occurs only in young children, given its present lethal prognosis, the scarcity of reported cases, and the lack of treatment guidelines.
Authors: Stefan Rutkowski; Udo Bode; Frank Deinlein; Holger Ottensmeier; Monika Warmuth-Metz; Niels Soerensen; Norbert Graf; Angela Emser; Torsten Pietsch; Johannes E A Wolff; Rolf D Kortmann; Joachim Kuehl Journal: N Engl J Med Date: 2005-03-10 Impact factor: 91.245
Authors: Marco Gessi; Felice Giangaspero; Libero Lauriola; Marina Gardiman; Bernd W Scheithauer; William Halliday; Cynthia Hawkins; Marc K Rosenblum; Peter C Burger; Charles G Eberhart Journal: Am J Surg Pathol Date: 2009-02 Impact factor: 6.394
Authors: Stefan Pfister; Marc Remke; Mirco Castoldi; Alfa H C Bai; Martina U Muckenthaler; Andreas Kulozik; Andreas von Deimling; Armin Pscherer; Peter Lichter; Andrey Korshunov Journal: Acta Neuropathol Date: 2008-12-05 Impact factor: 17.088
Authors: David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues Journal: Acta Neuropathol Date: 2007-07-06 Impact factor: 17.088
Authors: V Dangouloff-Ros; A Tauziède-Espariat; C-J Roux; R Levy; D Grévent; F Brunelle; A Gareton; S Puget; K Beccaria; T Blauwblomme; J Grill; C Dufour; P Varlet; N Boddaert Journal: AJNR Am J Neuroradiol Date: 2019-03-07 Impact factor: 3.825
Authors: Petra Mozes; Péter Hauser; Tibor Hortobágyi; Gábor Benyó; István Peták; Miklós Garami; Adrienne Cserháti; Katalin Bartyik; László Bognár; Zoltán Nagy; Eszter Turányi; Katalin Hideghéty Journal: J Neurooncol Date: 2015-09-15 Impact factor: 4.130
Authors: Kayleen Bailey; Neeta Pandit-Taskar; John L Humm; Pat Zanzonico; Stephen Gilheeney; Nai-Kong V Cheung; Kim Kramer Journal: J Neurooncol Date: 2019-03-16 Impact factor: 4.130
Authors: Shawn L Hervey-Jumper; David B Altshuler; Anthony C Wang; Xiaobing He; Cormac O Maher; Patricia L Robertson; Hugh J L Garton; Xing Fan; Karin M Muraszko; Sandra Camelo-Piragua Journal: Brain Pathol Date: 2013-08-12 Impact factor: 6.508
Authors: Andrey Korshunov; Dominik Sturm; Marina Ryzhova; Volker Hovestadt; Marco Gessi; David T W Jones; Marc Remke; Paul Northcott; Arie Perry; Daniel Picard; Marc Rosenblum; Manila Antonelli; Eleonora Aronica; Ulrich Schüller; Martin Hasselblatt; Adelheid Woehrer; Olga Zheludkova; Ella Kumirova; Stephanie Puget; Michael D Taylor; Felice Giangaspero; V Peter Collins; Andreas von Deimling; Peter Lichter; Annie Huang; Torsten Pietsch; Stefan M Pfister; Marcel Kool Journal: Acta Neuropathol Date: 2013-12-14 Impact factor: 17.088
Authors: Sergio Jaramillo; David R Grosshans; Nancy Philip; Ali Varan; Canan Akyüz; Mary Frances McAleer; Anita Mahajan; Susan L McGovern Journal: Clin Transl Radiat Oncol Date: 2018-11-07